Printed in U.S.A. quantitate I3CO2 elimination of breath, demethylation of aminopyrine was found to be positively correlated to age. By 20 wk of age, some infants had rates of elimination similar to those measured in adults. Absorption was excluded as a limiting variable, because no improvement in oxidation rates was found when the aminopyrine was readministered as an intravenous bolus. Changes in nutritional status and route of feeding (enteral versus parenteral) did not prevent the effect of maturation on aminopyrine elimination. Conclusions: 1) maturational differences are seen in the metabolism of aminopyrine; 2) these differences may reflect immaturity of N-demethylase activity or diversion of the liberated formaldehyde into biosynthetic rather than oxidative pathways. (Pediatr Res 19: 441-445, 1985) 442 SHULMAN ET AL.
The hepatic P 450 cytochrome monooxygenase enzyme complex is responsible for the metabolism of a myriad of xenobiotics. Available information suggests that the P 450 system undergoes maturational increases in activity (I, 2). One of the in vivo markers that has been used to measure P 450 activity has been the capacity of hepatocytes to demethylate aminopyrine (3) (4) (5) . By labeling the methyl group with I4C or the nonradioactive isotope, "C, an in vivo assessment of demethylating capacity can be made. After demethylation, the labeled methyl group is converted to formaldehyde, formate, and eventually the carbon is excreted in breath carbon dioxide (6) .
Although the aminopyrine breath test has been used for a number of years in adults, there is little experience with the application of the test in infants and children (7) . Because demethylation is dependent on cytochrome activity, the utilization of the aminopyrine breath test in children affords a unique method to examine the time course of the postnatal development of demethylase function. The aims of this study, ,therefore, were to determine age-related changes in N-demethylase activity as demonstrated by the aminopyrine breath test and to ascertain the time course for development of such changes.
METHODS
Subjects. Sixteen hospitalized infants less than I yr of age were studied ( Table I ). The subjects had neither a history of liver disease nor evidence of liver disease on clinical examination. Serum alanine transaminase, aspartate transaminase, alkaline phosphatase, total and direct bilirubin were normal in all infants. None of the infants had lung disease or were on drugs known to affect hepatic function. Because a hospitalized population was studied and nutritional status could potentially affect the results of the breath test, nutritional assessments were performed, using the clinical examination and weight to height and arm to head circumference ratios (Table I ( 8, 9) . The infants were fasted for a minimum of 2 h before the oral administration of 2 mg/kg of aminopyrine. Although aminopyrine is rapidly and completely absorbed (1 O), selected infants were given the drug both orally and intravenously in random order on sequential days to rule out the effects of gastrointestinal function, as a variable, on the results. Additionally, sequential studies were obtained in some of the infants. Breath samples were collected 30, 15, and 0 min before and at 30-min intervals up to 4 h, then hourly for a total of 6 h after the oral administration of the aminopyrine. When the drug was given intravenously, breath samples were collected at -30, -15, 0, 1, 2, 3, 5, 7, 10, 15, 20, 30,45, and 60 min, after which the collection times were the same as those for the oral studies.
Breath samples were obtained using a face mask fitted with one-way valves with the expiration valve attached to a collection bag (I 1). Samples were transferred to 50-ml Vacutainers (Becton, Dickinson & Co., Rutherford, NJ) for storage (12) . Total CO2 production was determined hourly during the test by sweeping the mask with a known rate of air flow and analyzing the sample for C02 concentration (I 1).
Although there has been no documentation of a case of neutropenia resulting from the use of aminopyrine for a breath test, rare cases have occurred after continuous use of the drug. Thus, as a precaution, a complete blood count was obtained before and 24 h after each breath test. TPN  TPN  TPN  TPN  TPN  TPN  TPN  Oral  Oral  TPN  TPN   PO$, IV §  PO  PO, IV  PO, IV  PO  PO  PO  PO, IV  PO, IV  PO, IV  PO, 11 Malnourished (wt/ht < 5%, arm/head circumference ratio < 0.31) (8, 9) . 
Analytical procedures. Isotopic composition (L3C02/'2C02) in
breath was determined using a dual inlet gas isotope ratio mass spectrometer (1 3). Carbon dioxide concentration was measured using gas chromatography (1 4).
Data analysis. C02 production values (pmol/kg/min) for each infant were averaged and the mean was used in calculations of percentage dose recovery determined from the I3C enrichment of breath C02 (1 5) . The I3CO2 breath test curves were evaluated using scoring techniques which have been described in detail elsewhere (1 5-17) . In brief, the cumulative percentage dose recovered over the first 2 h of the study was calculated from the trapezoidal integration of a plot of percentage dose expiredlh versus time from zero to 120 min; the maximum percentage dose expiredlh and the percentage dose recovered at 2 h were determined by inspection of the breath test curve; the total percentage dose recovery was calculated from the area under the curve of the percentage dose of labeled COz expiredlh; the disappearance rate constant (Kb) was obtained from the slope of the least-squares regression line fitted to a semi-log plot of percentage dose expiredlh from 120 min to 6 h. A graphic summary of these methods is depicted in Figure 1 .
Differences between age groups for the scored results were compared using Student's t test. The mean values of the breath test results for individual infants in whom multiple tests were camed out were used in the comparisons between different age groups. Results of studies in the same infant were compared using a paired t test. The relationships between age and breath test scores, nutritional status, and type of diet (enteral or parenteral nutrition) were analyzed using multiple regression analysis.
RESULTS
The percentage dose expiredlh after oral administration of the drug is shown in Figure 2 . Except for infant 2 (vide infra), there was little or no increase in breath I3CO2 in infants between 1 and 4 wk of age following administration of the aminopyrine. At 5 to 7 wk, some infants began to show a small increase in the percent dose eliminated per hour. In the 14-to 19-wk age group, the percentage dose excreted rose sharply over the first 60 min and then decreased gradually over the next 5 h; these results are similar to those seen in aminopyrine breath studies carried out in adults (15) . In the infants studied between 27 and 38 wk, interindividual differences in drug elimination were apparent, but overall there was increased elimination when compared to the younger infants. suggested by various authors (1 5-17) were used in the analyses. DISCUSSION The cumulative percentage dose recovered over 2 h (Cum% 2 h), the maximum percentage dose expired/h (Max% exp), the The present study is consistent with investigations camed out percentage dose recovered at 2 (% Dose 2 h), and the total in rats which have demonstrated age-related changes in aminopercentage dose (Tot% 6 h) recovered over 6 h were greater in pyrine demethylase 8). The IIIaturation of activity the infants aged 16 to 36 wk with those in infants aged measured in vitro correlated with increases in drug elimination 1 to 4 or 5 to 8 wk. No differences were seen in the mean found in viva (I8). b 20-versus 3.4 + 3.2). All the breath test scores except mean disap-> pearance rate constants showed a significant correlation with age 0 (Fig. 3) . 
15-
In order to examine changes in drug elimination with age in an individual, sequential studies were camed out in eight infants. Because the route of feeding or nutritional status changed in 4 10-some subjects who had more than one study, the results of only one test were included in any given regression. Once again, a o significant correlation with age was seen, but no effect of nutri-5 -tional status or route of feeding was found. Although interindi-I L vidual differences in aminopyrine elimination were evident, overall within individuals there was an increase in the cumulative 0 percentage dose recovered over 2 h (Fig. 4) . were performed. Numbers are patient numbers; see Table I , column I . Fig. 3. Correlation between mean breath test scores and age for the orally administered aminopyrine. A, cumulative percent dose expired over  twohours, y=5.2+0.336x,r=0.7,p<0.005.B,Max%exp,y=4.43+0.24x,r=0.7,p<0.005.C,%Dose2h,y=2.79+0.216x,r=0.6 Studies that examine the maturation of drug metabolizing capacity in humans, however, have been limited, for the most part, to in vitro work done with human liver obtained from fetuses after abortion or from infants who have died. These investigations have shown the presence of cytochrome P 450, albeit diminished in concentration compared to that in adults (3) (4) (5) . The amount of P 450 per se, however, does not necessarily reflect drug metabolizing capacity (1 9) . The components of the monooxygenase complex, such as NADPH-cytochrome c reductase or aminopyrine N-demethylase, show a better correlation with in vivo drug metabolism (19) . Aranda et al. (20) found overlap in the amount of aminopyrine demethylase activity between fetal and adult liver tissues; however, some of the infants in their study had received drugs known to stimulate demethylase activity. In addition, the infants and adults who were studied had severe illnesses prior to death, a factor which may have affected the results. The results of the present study suggest that the capacity to eliminate the labeled methyl group increases with age (Fig. 3) .
The findings of this investigation are consistent with those of studies in infants in which increases in the serum clearance of aminopyrine with age were demonstrated (2 1). Jaeger-Roman et al. (7) studied a small number of infants with the aminopyrine breath test and found that the amount of labeled C02 eliminated in breath increased with age. The maximum percentage dose I3CO2 eliminated per hour was lower than that found in the present study. Our results, however, are not directly comparable to those of Jaeger-Roman et al. (7) because the C02 production rate was not measured in their study. ' In two of the infants who underwent sequential studies, the increases in drug elimination were quite marked (patients 2 and 16). It cannot be determined with certainty whether demethylation in these individuals initially was retarded or subsequently induced. Because their clinical status was little different from that of the other infants, and they, as the others, did not receive drugs that could induce hepatic function, the increases in elimination of the label probably reflected maturation. There are no data to suggest that repeat doses of aminopyrine increase its subsequent rate of metabolism. Repetitive studies canied out in adults give reproducible results.
The large SDs in the elimination constant, which showed no differences among groups, likely were related to the uneveness of the I3CO2 elimination curves seen in some of the infants. The lack of smoothness in the curves may have resulted in part from a small increase in I3CO2 after drug administration, which occurred against a varying background level of I3C found in foodstuffs (22) .
It is unclear whether malnutrition impairs (23) or stimulates (24) drug elimination. In the present study, increases in the elimination of the "C label in breath with age were seen regardless of the infant's nutritional status. Indeed, patients 15 and 16 who were malnourished and whose nutritional status did not change over the study period showed an increase in "C02 elimination when studied at an older age. Animal studies suggest that fasting itself has little effect on aminopyrine kinetics (25) .
Certain factors must be borne in mind in the final interpretation of the results. Approximately 50% of the I3C label after leaving the aminopyrine molecule is excreted as I3CO2 in breath (15, 26) ; the remainder is shunted into other pathways such as urinary metabolites and bicarbonate (15) . Additionally, it has been suggested that pathways other than demethylation exist for the monomethyl moiety (26) . Although the results of many studies support the relationships among elimination of label in breath, hepatic function, and demethylating capacity, further investigation is needed to clarify the effect that alternate pathways of elimination and the one carbon pool (27, 28) may have on the results.
' In this paper (7), the column designated maximal 13C02/h (I3C mmol/h) was mislabeled and should be % dose/h (Helge H, personal communication, 1982) .
